#Ozempic

6 articles with this tag

GLP-1 Rule 702 Hearing: What Sept. 10-18 Decides

Judge Marston holds a Rule 702 hearing Sept. 10-18, 2026 on whether GLP-1 causation experts can testify in MDL 3094, where 3,928 cases are pending.

mass tort GLP-1 Ozempic+5

Sep 3, 2026

Read

GLP-1 Vision Loss MDL Grows 70% Ahead of September Hearings

Mass Tort News

8 min read

GLP-1 Vision Loss MDL Grows 70% Ahead of September Hearings

The GLP-1 NAION vision-loss MDL hit 146 cases on the July JPML report (up 70% in two months) as the GI-injury MDL heads to Rule 702 hearings September 10-18.

mass tort GLP-1 Ozempic+4

Jul 10, 2026

Read

New GLP-1 Pill Approved as Ozempic MDL Nears Trial

Mass Tort News

6 min read

New GLP-1 Pill Approved as Ozempic MDL Nears Trial

FDA approves Eli Lilly's Foundayo (the first oral GLP-1 with no fasting requirement) as 3,363 pending GLP-1 lawsuits approach critical deadlines.

mass tort GLP-1 Ozempic+2

Apr 7, 2026

Read

FDA Warns Novo Nordisk on Unreported Deaths

Legal Updates

7 min read

FDA Warns Novo Nordisk on Unreported Deaths

FDA cites 'systemic failures' in Novo Nordisk's adverse event reporting for Ozempic and Wegovy, including unreported patient deaths.

Ozempic FDA mass tort+2

Mar 24, 2026

Read

4,400 GLP-1 Lawsuits Filed: What Firms Need to Know

Mass Tort News

6 min read

4,400 GLP-1 Lawsuits Filed: What Firms Need to Know

GLP-1 drug lawsuits surged 130% in 2025, with 75% alleging gastroparesis. A Rule 702 expert hearing is set for September 2026.

mass tort GLP-1 Ozempic+2

Feb 3, 2026

Read

Ozempic Litigation Comprehensive Guide: August 2025 Updates and Medical Record Challenges

Mass Tort News

10 min read

Ozempic Litigation Comprehensive Guide: August 2025 Updates and Medical Record Challenges

Guide to Ozempic litigation including Judge Marston's evidentiary ruling, NAION vision loss claims, and managing medical record requirements in MDL 3094.

Ozempic mass torts gastroparesis+4

Sep 22, 2025

Read